Nektar Therapeutics
NASDAQ:NKTRBiotechnology
Healthcare
$32.54 -2.04%
-$1.24 today
- Market cap
- $933.51M
- Beta
- 1.15
- P/E (TTM)
- -9.3
- EPS (TTM)
- -$6.39
52W Low $8.27High $109.00
Volume 0.86M
Average 1.00M
Private 5-step workspace
Build a NKTR investment thesis
Turn Nektar Therapeutics research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.